000 01393 a2200397 4500
005 20250518014324.0
264 0 _c20190321
008 201903s 0 0 eng d
022 _a1768-3254
024 7 _a10.1016/j.ejmech.2018.12.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeleu-Chavain, Natascha
245 0 0 _aBenzo[d]thiazol-2(3H)-ones as new potent selective CB
_h[electronic resource]
260 _bEuropean journal of medicinal chemistry
_cMar 2019
300 _a347-362 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Inflammatory Agents
_xchemistry
650 0 4 _aBenzothiazoles
_xchemistry
650 0 4 _aCannabinoid Receptor Agonists
_xchemistry
650 0 4 _aColon
_xpathology
650 0 4 _aHumans
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aReceptor, Cannabinoid, CB2
_xagonists
650 0 4 _aStructure-Activity Relationship
700 1 _aBaudelet, Davy
700 1 _aHeloire, Valéria Moas
700 1 _aRocha, Diana Escalante
700 1 _aRenault, Nicolas
700 1 _aBarczyk, Amélie
700 1 _aDjouina, Madjid
700 1 _aBody-Malapel, Mathilde
700 1 _aCarato, Pascal
700 1 _aMillet, Régis
773 0 _tEuropean journal of medicinal chemistry
_gvol. 165
_gp. 347-362
856 4 0 _uhttps://doi.org/10.1016/j.ejmech.2018.12.008
_zAvailable from publisher's website
999 _c29196347
_d29196347